SAN JOSE, Calif.
Sept. 12, 2013
. (NASDAQ: OCLR), a leading provider and innovator of optical communications solutions, today announced that it has sold its Oclaro Switzerland GmbH subsidiary and associated laser diodes business to
(NASDAQ:IIVI) in a transaction valued at
. In addition, II-VI acquired an exclusive option to purchase Oclaro's optical amplifier and micro-optics business for
"The sale of our Gallium Arsenide laser diode business is an important first step in our plan to restructure the company," said
, CEO, Oclaro. "The
-based business, including the team and its rich legacy, is a valuable asset and we wish II-VI and the team much future success. We will use the proceeds from the sale to fully repay our bridge financing and to begin restructuring the company for the future. We intend to further simplify our operating footprint, reduce our cost structure and focus our R&D investment in the optical communications market where we can leverage our core competencies."
Of the total transaction value of
, Oclaro received
in cash today. Oclaro will retain the existing accounts receivable of the business, estimated at approximately
. The remaining
is being held by II-VI subject to traditional post-closing conditions.
As part of the agreement, II-VI has purchased the Oclaro
company, which includes its GaAs fabrication facility, and also the corresponding high power laser diodes, VCSEL and 980nm pump laser product lines, including intellectual property, inventory, equipment and a related R&D facility in
all of which are associated with these businesses ("the
business"). Revenues for the
business were approximately
for the fiscal year ended
June 29, 2013
Oclaro will continue the back-end manufacturing of the 980nm pump and some high power laser diode products at its
manufacturing facility and supply them to II-VI under a manufacturing services agreement. The employees of
will continue to be employed by Oclaro. In addition, various supply and transition service agreements have been established between the companies to ensure a smooth transition.
The option to purchase Oclaro's optical amplifier and micro-optics business, for which II-VI separately paid
in cash, will expire if not exercised within 30 days. If this option is exercised and II-VI purchases the amplifier and micro-optics business, the option price will be applied to the purchase price. If II-VI does not exercise this option, the
payment will be retained by Oclaro.
Total proceeds received by Oclaro today were
Foros and Imperial Capital acted as financial advisors to Oclaro.